RxDoctor Payments Data

Kevin Pulsipher, DO

Family Medicine · Cedaredge, CONPI 1093754491

Payments from drug & device makers

$625in general payments, 2019–2025

Across 35 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$133
  • GSK$86
  • AstraZeneca$61
  • Astellas Pharma US Inc$61
  • Pfizer$53
  • Grifols USA, LLC$46
  • plus $186 from 8 others

What the payments were for

  • Food & beverage$60997%
  • Education$163%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$625 in reported general payments places this provider in the 75th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$149,258
Medicare patients
327
Services billed
3,526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban146$90,241
OzempicSemaglutide66$72,354
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$53,682
XifaxanRifaximin25$47,507
Breo ElliptaFluticasone/Vilanterol62$45,188
JardianceEmpagliflozin24$35,763
JanuviaSitagliptin Phosphate36$28,300
XareltoRivaroxaban21$25,298
TrulicityDulaglutide29$24,074
Tresiba Flextouch U-100Insulin Degludec19$16,930
Spiriva RespimatTiotropium Bromide16$16,874
SymbicortBudesonide/Formoterol Fumarate25$10,223
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm22$6,780
Atrovent HfaIpratropium Bromide13$6,661
Gabapentin432$6,642

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$86$104,374140 claims
PfizerEliquis$53$90,241146 claims
Johnson & JohnsonXarelto$28$25,29821 claims
Lilly USA, LLCTrulicity$23$24,07429 claims
AstraZenecaSymbicort$61$10,22325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Cedaredge

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →